Skip to Main Content

Paper Details

Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.
Front Oncol
7
2019
CD4+, CD4+ T cells, CD8, CD8+, CD8+ and CD4+ T cells, MHC-I and -II, MM, MM cells, MM tumors, Malignant Mesothelioma, Mice, OX40, OX40 Receptor, T regulatory cells, asbestos, autoimmune, cancer, mesothelial cells, mice, p-Tvax, tumor, tumor-infiltrating CD8+ and CD4+ T cells, tumors
Author NameAffiliation
Youping DengJohn A. Burns School of Medicine, University of Hawai'i
Youping DengJohn A. Burns School of Medicine, University of Hawai'i
Leonard MoiseInc.
Leonard MoiseInstitute for Immunology and Informatics, University of Rhode Island
Anne S De GrootInc.
Anne S De GrootInstitute for Immunology and Informatics, University of Rhode Island
  • 1 - 6

Datasets

Release 1.2